Symposium & advanced training at the IOZK: Immunotherapy in neuro-oncology, Fri. 06.09.2019
In recent years, immunotherapy has established itself as the fourth pillar of cancer therapy alongside surgery, radiotherapy and chemotherapy. The use of immunotherapy in neuro-oncology is associated with particular challenges but also with great hopes.
To mark the opening of its new GMP laboratory, the IOZK will be hosting a scientific symposium with international speakers on the subject of "Immunotherapy in neuro-oncology". A tour of the laboratories is one of the items on the agenda and we look forward to seeing you there.
Fri. 06.09.2019 | 10:00-18:00 | Steigenberger Hotel Cologne | Habsburgerring 9-13 | 50674 Cologne
CME points: 9 | The number of participants is limited. The conference fee is 45,00 €.
Venue: Steigenberger Hotel Cologne | Habsburgerring 9-13 | 50674 Cologne
GMP laboratory: IOZK Immune Oncology Center Cologne | Hohenstaufenring 30-32 | 50674 Cologne
Please use the attached registration form and send it to us by fax, e-mail or post.
Download: Invitation (Pdf)
Download: Registration (Pdf)
Scientific Program
09:30 Registration
Location: Steigenberger Hotel Cologne
10:00 -10:15 Welcome
Dr. Wilfried Stücker | Management and head of the IOZK working group | IOZK Immuno-Oncology Center Cologne
10:15 -10:45
Molecular detection of circulating tumor cells and characterization of therapy-related drug
metabolizing genes
Dr. Lothar Prix | Labordiagnostik | LADR Laborzentrum Recklinghausen | Germany
10:45 -11:15
Results against glioblastoma by Sitoiganap
Prof. Dr. Apostolos Stathopoulos | Head of Neurosurgery | Euroclinic, | Athens, Greece
11:15 -11:45
Future developments of brain tumor vaccines
Prof. Dr. Matthias Eyrich | Pediatric Clinic | University Hospital Würzburg | Germany
11:45 -12:15
Multimodal Immunotherapy at IOZK
Stefaan Van Gool MD. PhD. | Translational Oncology | IOZK Immuno-Oncology Center Cologne | Germany
12:15 -14:15
Lunch and guided visit to the IOZK clinical unit and the IOZK GMP laboratory
Location: IOZK Center | Immun-Onkologisches Zentrum Köln | Hohenstaufenring 30-32, 50674 Cologne,
14:15 -14:45
Immuno-radiotherapy to prevent brain metastases from lung cancer
Prof. Dr. Dirk de Ruysscher | Radiooncology | Maastricht University | Netherlands
14:45 -15:15
GlioVax: Dendritic cell vaccination therapy of glioblastoma
PD Dr. Rüdiger Sorg | Institute for Transplantation Diagnostics & Cell Therapeutics | Heinrich Heine University Düsseldorf | Germany
15:15 -15:45
Oncolytic virus for pediatric brain tumors: from the bench to the clinic
Prof. Dr. Marta Alonso | Pediatric Clinic | Clinica Universidad Navarra | Pamplona, Spain
15:45 -16:15 Coffee break
16:15 -16:45
Update on clinical results from a cohort of GBM patients treated with autologous dendritic cells
Prof. Dr. Ricardo Díez Valle | Neurosurgery | Clinica Universidad Navarra | Pamplona, Spain
16:45 -17:15
Immune monitoring of glioblastoma patients treated with dendritic cell immunotherapy
Prof. Dr. Serena Pellegatta | Molecular Neurooncology | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Milan, Italy
17:15 -17:45
The Pan Tum Detect blood test (Apo10, TKTL1) and current immunophenotyping to monitor the response to immunotherapy
Dr. Oliver Feyen | Laboratory Diagnostics | IOZK Immuno-Oncology Center Cologne | Germany
17:45 -18:00 Closing remarks
Dr. Wilfried Stücker | Management and head of the IOZK working group | IOZK Immuno-Oncology Center Cologne
